Avalyn Pharma Inc.
AVLN$26.99▲ 2.23% 24h
$26.99
+$0.9291(+3.56%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$1.20B
P/E ratio
—
EPS (diluted)
$-21.83
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
—
Net income
$-26.87M
Net margin
—
Gross margin
—
Dividends & financials
Avalyn Pharma Inc. (AVLN) reported revenue of — and net income of $-26.87M, or $-21.83 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.
